GKB Ophthalmics P/E Ratio
GKB Ophthalmics (GKB) P/E ratio is not applicable — EPS (TTM) ₹-13.98. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-13.98
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | 3.17 | 2 | Profit |
| Mar 2025 | -7.03 | -4 | Loss |
| Jun 2025 | -2.02 | -1 | Loss |
| Dec 2025 | 0.08 | 1 | Profit |
| Sept 2024 | -2.41 | -1 | Loss |
| Mar 2024 | -1.81 | -1 | Loss |
| Jun 2024 | -0.50 | 0 | Loss |
| Dec 2024 | -4.03 | -2 | Loss |
Healthcare Peers with Valid P/E Ratios — GKB Comparison
Healthcare sector average P/E 52.69, median 27.2 — GKB excluded (negative EPS).
Sector Average PE
52.69
Sector Median PE
27.2
Lowest PE
1.03
Profitable Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.85 | ₹71 | Low |
| Shelter Pharma | SHELTER | 7.0 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹74 | Low |
| Par Drugs & Chemical | PAR | 8.21 | ₹114 | Low |
| Medicamen Organics | MEDIORG | 8.76 | ₹35 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see GKB Ophthalmics share price chart.
- Analyse GKB Ophthalmics ownership structure to track promoter, FII and institutional holdings.
- View GKB price range for the annual high/low range and current price position.